详情页 - 四川省肿瘤医院知识库

当前位置：首页 > 详情页

A real-world, population-based study of the trends for incidence and prognosis in high-grade neuroendocrine tumor of cervix.

9| 认领 | 导出 | 链接全文 |

文献详情

资源类型：

WOS体系：

Pubmed体系：

收录情况： ◇ SCIE

作者：

机构： [1]Department of Radiation Oncology, Chengdu Women’s and Children’s Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China [2]Department of Oncology, Chengdu Second People’s Hospital, Chengdu, China [3]Department of Medical Oncology, Sichuan Cancer Hospital & Institute, Chengdu, China [4]Department of Oncology, The first affiliated hospital of Chongqing Medical University, Chongqing, China [5]Department of Radiology, Chengdu Women’s and Children’s Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China

出处：

DOI：

ISSN：

摘要：

To explore the incidence and prognosis trends for high-grade cervical neuroendocrine tumor (HGCNET) and construct a nomogram to predict prognosis for HGCNET. Annual age-adjusted incidence of HGCNET from 1975 to 2015 was retrieved from the Surveillance, Epidemiology, and End Results program, the linear regression, poisson regression and annual percentage changes were used to assess the incidence trend. Also, trends for relative survival (RS) and overall survival (OS) in HGCNET patients from 1975 to 2015 were evaluated. From 1988 to 1975, 514 HGCNET patients were selected and divided into two cohorts with a ratio of 7:3. Nomogram to predict OS for these patients was constructed and validated. The incidence trend for HGCNET was unchanged in the past four decades (P = 0.734), but the proportion of HGCNET in diagnosed cervical cancer slightly increased from 0.9% in 1975 to 1.9% in 2015 (P < 0.001). The 5-year RS and OS for HGCNET in the study periods decreased steadily (RS: P = 0.009; OS: P = 0.008). Nomogram incorporating age, T stage, lymph-node positive, distant metastasis and surgery was constructed. The C-index of the nomogram was 0.716 (0.680-0.752), which was higher than the FIGO staging system. The incidence of HGCNET remained unchanged in the past four decades but the proportion of HGCNET has slightly increased. Besides, a steadily decreasing survival for HGCNET was observed in the study periods. A nomogram was constructed to better predict prognosis for HGCNET.Copyright © 2021. Published by Elsevier Inc.

语种：

被引次数：

WOS：

PubmedID：

中科院(CAS)分区：

出版当年[2022]版：

大类 | 4 区医学

小类 | 4 区肿瘤学

最新[2023]版：

大类 | 4 区医学

小类 | 4 区肿瘤学

JCR分区：

出版当年[2022]版：

Q3 ONCOLOGY

最新[2023]版：

Q3 ONCOLOGY

影响因子： 2.5 最新[2023版] 2.7 最新五年平均 2.6 出版当年[2022版] 3.3 出版当年五年平均 2.367 出版前一年[2021版] 2.5 出版后一年[2023版]

第一作者：

第一作者机构： [1]Department of Radiation Oncology, Chengdu Women’s and Children’s Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China

通讯作者：

通讯机构： [1]Department of Radiation Oncology, Chengdu Women’s and Children’s Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China [5]Department of Radiology, Chengdu Women’s and Children’s Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China [*1]Department of Radiology, Chengdu Women’s and Children’s Central Hospital, School of Medicine, University of Electronic Science and Technology of China, No. 1617 of Riyue Ave, Qingyang District, Chengdu 611731, China. [*2]Department of Radiation Oncology, Chengdu Women’s and Children’s Central Hos- pital, School of Medicine, University of Electronic Science and Technology of China, No. 1617 of Riyue Ave, Qingyang District, Chengdu 611731, China.

推荐引用方式(GB/T 7714)：

APA：

MLA：